The HLA-G low expressor genotype is associated with protection against bipolar disorder

Human Immunology

Volumn 74, Issue 5, 2013, Pages 593-597

  Debnath, Monojit ^a,b   Busson, Marc ^a,f   Jamain, Stéphane ^b,c,d,e   Etain, Bruno ^b,c,d,e   Hamdani, Nora ^b,c,d,e   Oliveira, José ^a,b   Boukouaci, Wahid ^a,f   Amokrane, Kahina ^a,f   Moins Teisserenc, Hélène ^a,e,f   Lajnef, Mohamed ^b,c,d,e   Bengoufa, Djaouida ^a   Malafosse, Alain ^g   Bellivier, Frank ^b,c,d,e   Henry, Chantal ^b,c,d,e   Kahn, Jean Pierre ⁱ   Krishnamoorthy, Rajagopal ^a,e,h   Charron, Dominique ^a,e,f   Leboyer, Marion ^b,c,d,e   Tamouza, Ryad ^a,e,f  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM U955   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e FONDATION FONDAMENTAL   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITY OF GENEVA   (Switzerland)

^h HÔPITAL ROBERT DEBRÉ   (France)

ⁱ CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GENOMIC DNA; HLA G ANTIGEN;

ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA EXTRACTION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; INDEL MUTATION; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-G ANTIGENS; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; ODDS RATIO; POLYMORPHISM, GENETIC; SEASONS; SEQUENCE DELETION; YOUNG ADULT;

EID: 84876331324     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.11.032     Document Type: Article

References (58)

1. Collins P.Y., Patel V., Joestl S.S., March D., Insel T.R., Daar A.S., et al. Grand challenges in global mental health. Nature 2011, 475:27-30.
2. Serretti A., Mandelli L. The genetics of bipolar disorder: genome 'hot regions', genes, new potential candidates and future directions. Mol Psychiatry 2008, 8:742-771.
3. Lichtenstein P., Yip B.H., Björk C., Pawitan Y., Cannon T.D., Sullivan P.F., et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373:234-239.
4. Farmer A., Elkin A., McGuffin P. The genetics of bipolar affective disorder. Curr Opin Psychiatry 2007, 20:8-12.
5. Taylor L., Faraone S.V., Tsuang M.T. Family, twin, and adoption studies of bipolar disease. Curr Psychiatry Rep 2002, 4:130-133.
6. Moore P.B., El-Badri S.M., Cousins D., Shepherd D.J., Young A.H., McAllister, et al. White matter lesions and season of birth of patients with bipolar affective disorder. Am J Psychiatry 2001, 158:1521-1524.
7. Goldstein B.I., Kemp D.E., Soczynska J.K., McIntyre R.S. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 2009, 70:1078-1090.
8. Hamdani N., Tamouza R., Leboyer M. Immuno-inflammatory markers of bipolar disorder: a review of evidence. Front Biosci (Elite Ed) 2012, 4:2170-2182.
9. Blume J., Douglas S.D., Evans D.L. Immune suppression and immune activation in depression. Brain Behav Immun 2011, 25:221-229.
10. Clerici M., Arosio B., Mundo E., Cattaneo E., Pozzoli S., Dell'osso B., et al. Cytokine polymorphisms in the pathophysiology of mood disorders. CNS Spectr 2009, 14:419-425.
11. Czerski P.M., Rybakowski F., Kapelski P., Rybakowski J.K., Dmitrzak-Weglarz M., Leszczyńska-Rodziewicz A., et al. Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population. Neuropsychobiology 2008, 57:88-94.
12. Padmos R.C., Bekris L., Knijff E.M., Tiemeier H., Kupka R.W., Cohen D., et al. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol Psychiatry 2004, 56:476-482.
13. Vonk R., van der Schot A.C., Kahn R.S., Nolen W.A., Drexhage H.A. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?. Biol Psychiatry 2007, 62:135-140.
14. Eaton W.W., Pedersen M.G., Nielsen P.R., Mortensen P.B. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord 2010, 12:638-646.
15. Terayama H., Nishino Y., Kishi M., Ikuta K., Itoh M., Iwahashi K. Detection of anti-Borna Disease Virus (BDV) antibodies from patients with schizophrenia and mood disorders in Japan. Psychiatry Res 2003, 120:201-206.
16. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Cole S., Krivogorsky B. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry 2004, 55:588-593.
17. Hornig M., Briese T., Licinio J., Khabbaz R.F., Altshuler L.L., Potkin S.G. Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry 2012, 17:486-493.
18. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752. International Schizophrenia Consortium.
19. Figueiredo T.C., de Oliveira J.R. Reconsidering the association between the major histocompatibility complex and bipolar disorder. J Mol Neurosci 2011, 47:26-30.
20. Rouas-Freiss N., Marchal R.E., Kirszenbaum M., Dausset J., Carosella E.D. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?. Proc Natl Acad Sci USA 1997, 94:5249-5254.
21. Wiendl H., Mitsdoerffer M., Hofmeister V., Wischhusen J., Bornemann A., Meyermann R., et al. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 2002, 168:4772-4780.
22. Bainbridge D.R., Ellis S.A., Sargent I.L. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol 2000, 48:17-26.
23. Paul P., Cabestre F.A., Ibrahim E.C., Lefebvre S., Khalil-Daher I., Vazeux G., et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000, 61:1138-1149.
24. Larsen M.H., Hviid T.V. Human leukocyte antigen-G polymorphism in relation to expression, function, and disease. Hum Immunol 2009, 70:1026-1034.
25. Chen X.Y., Yan W.H., Lin A., Xu H.H., Zhang J.G., Wang X.X. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008, 72:335-341.
26. Rizzo R., Hviid T.V., Govoni M., Padovan M., Rubini M., Melchiorri L. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 2008, 71:520-529.
27. Boukouaci W., Busson M., Fortier C., Amokrane K., Peffault de Latour R., Robin M. Association of HLA-G low expressor genotype with severeacute graft-versus-host disease after sibling bone marrow transplantation. Front Immunol 2011, 2:74-79.
28. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Paris: Masson; 1994.
29. Nurnberger Jr. JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH genetics initiative. Arch Gen Psychiatry 1994; 51: 849-59 and 863-4.
30. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
31. Bech P., Rafaelsen O.J., Kramp P., Bolwig T.G. The mania rating scale: scale construction and interobserver agreement. Neuropharmacology 1978, 17:430-431.
32. Maxwell ME. Manual for the family interview for genetic studies. NIMH; 1992.
33. Tripathi P., Abbas A., Naik S., Agrawal S. Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 2004, 64:706-710.
34. Drexhage R.C., Hoogenboezem T.H., Versnel M.A., Berghout A., Nolen W.A., Drexhage H.A. The activation of monocyte and T cell networks in patients with bipolar disorder. Brain Behav Immun 2011, 25:1206-1213.
35. Donadi E.A., Castelli E.C., Arnaiz-Villena A., Roger M., Rey D., Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011, 68:369-395.
36. O'Brien M., McCarthy T., Jenkins D., Paul P., Dausset J., Carosella E.D., et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001, 58:1943-1949.
37. Rousseau P., Le Discorde M., Mouillot G., Marcou C., Carosella E.D., Moreau P. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003, 64:1005-1010.
38. Hviid T.V., Hylenius S., Rørbye C., Nielsen L.G. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003, 55:63-79.
39. Veit T.D., Chies J.A. Tolerance versus immune response - microRNAs as important elements in the regulation of the HLA-G gene expression. Transpl Immunol 2009, 20:229-231.
40. Castelli E.C., Mendes-Junior C.T., Deghaide N.H., de Albuquerque R.S., Muniz Y.C., Simões R.T. The genetic structure of 3' untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun 2010, 11:134-141.
41. Tan Z., Randall G., Fan J., Camoretti-Mercado B., Brockman-Schneider R., Pan L. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007, 81:829-834.
42. Yie S.M., Li L.H., Xiao R., Librach C.L. A single base-pair mutation in the 3'-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod 2008, 14:649-653.
43. Larsen M.H., Hylenius S., Andersen A.M., Hviid T.V. The 3'-untranslated region of the HLA-G gene in relation to pre-eclampsia: revisited. Tissue Antigens 2010, 75:253-261.
44. Onno M., Pangault C., Le Friec G., Guilloux V., Andre P., Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000, 164:6426-6434.
45. Lozano J.M., Gonzalez R., Kindelan J.M., Rouas-Freiss N., Caballos R., Dausset J. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. Aids 2002, 16:347-351.
46. Dickerson F., Kirkpatrick B., Boronow J., Stallings C., Origoni A., Yolken R. Deficit schizophrenia: association with serum antibodies to cytomegalovirus. Schizophr Bull 2006, 32:396-400.
47. Niebuhr D.W., Millikan A.M., Cowan D.N., Yolken R., Li Y., Weber N.S. Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry 2008, 165:99-106.
48. Ferszt R., Severus E., Bode L., Brehm M., Kühl K.P., Berzewski H. Activated Borna disease virus in affective disorders. Pharmacopsychiatry 1999, 32:93-98.
49. Liu J., Li J., Li T., Wang T., Li Y., Zeng Z., et al. CTLA-4 confers a risk of recurrent schizophrenia, major depressive disorder and bipolar disorder in the Chinese Han population. Brain Behav Immun 2011, 25:429-433.
50. Yan W.H. HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy. Endocr Metab Immune Disord Drug Targets 2011, 11:76-89.
51. Torrey E.F., Miller J., Rawlings R., Yolken R.H. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res 1997, 28:1-38.
52. Tsuchiya K.J., Byrne M., Mortensen P.B. Risk factors in relation to an emergence of bipolar disorder: a systematic review. Bipolar Disord 2003, 5:231-242.
53. Yolken R., Karlsson H., Yee F., Johnston-Wilson N.L., Torrey E.F. Endogenous retroviruses and schizophrenia. Brain Res Brain Res Rev 2000, 31:193-199.
54. Frank O., Giehl M., Zheng C., Hehlmann R., Leib-Mosch C., Seifarth W. Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorder. J Virol 2005, 79:890-901.
55. Weis S., Llenos I.C., Sabunciyan S., Dulay J.R., Isler L., Yolken R. Reduced expression of human endogenous retrovirus (HERV)-W GAG protein in the cingulate gyrus and hippocampus in schizophrenia, bipolar disorder, and depression. J Neural Transm 2007, 114:645-655.
56. Griffiths DJ. Endogenous retroviruses in the human genome sequence. Genome Biol 2001; 2: REVIEWS1017.
57. Nellaker C, Yao Y, Jones-Brando L, Mallet F, Yolken RH, Karlsson H. Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology 2006; 3: 44.
58. Perron H., Suh M., Lalande B., Gratacap B., Laurent A., Stoebner P. Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J Gen Virol 1993, 74:65-72.